Low-dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune disease

European Journal of Haematology

Volumn 97, Issue 1, 2016, Pages 78-82

  Blank, Norbert ^a   Lisenko, Katharina ^a   Pavel, Petra ^b   Bruckner, Thomas ^a   Ho, Anthony D ^a   Wuchter, Patrick ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Heidelberg GmbH   (Germany)

Author keywords

cyclophosphamide; leukapheresis; systemic sclerosis

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; DISEASE DURATION; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; HOSPITAL PATIENT; HUMAN; INTERMETHOD COMPARISON; LEUKAPHERESIS; LOW DRUG DOSE; MALE; MULTIPLE SCLEROSIS; OUTPATIENT; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SCLERODERMA; STEM CELL MOBILIZATION; SYSTEMIC SCLEROSIS; VASCULITIS;

EID: 84976310433     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12686     Document Type: Article

References (17)

1. LeRoy EC. Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am 1996;22:675–94.
2. van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 2013;72:1747–55.
3. Cutolo M, Sulli A, Pizzorni C, et al. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000;27:155–60.
4. Cipriani P, Di Benedetto P, Ruscitti P, et al. Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features. Arthritis Res Ther 2014;16:442.
5. Carrai V, Miniati I, Guiducci S, et al. Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. Rheumatology 2012;51:1042–8.
6. Cipriani P, Guiducci S, Miniati I, et al. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. Arthritis Rheum 2007;56:1994–2004.
7. Ludwig A, Saffrich R, Eckstein V, et al. Functional potentials of human hematopoietic progenitor cells are maintained by mesenchymal stromal cells and not impaired by Plerixafor. Cytotherapy 2014;16:111–21.
8. Burk AS, Monzel C, Yoshikawa HY, et al. Quantifying adhesion mechanisms and dynamics of human hematopoietic stem and progenitor cells. Sci Rep 2015;5:9370.
9. Wein F, Pietsch L, Saffrich R, et al. N-Cadherin is expressed on human hematopoietic progenitor cells and mediates interaction with human mesenchymal stromal cells. Stem Cell Res 2010;4:129–39.
10. Boulais PE, Frenette PS. Making sense of hematopoietic stem cell niches. Blood 2015;125:2621–9.
11. Van Laar JM, Tyndall A. Intense immunosuppression and stem-cell transplantation for patients with severe autoimmune disease: a review. Cancer Control 2003;10:57–65.
12. Gratwohl A, Passweg J, Bocelli-Tyndall C, et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2005;35:869–79.
13. Burt RK, Shah SJ, Dill K, et al. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial. Lancet 2011;378:498–506.
14. van Laar JM, Farge D, Sont JK, et al. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA 2014;311:2490–8.
15. Snowden JA, Saccardi R, Allez M, et al. Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2012;47:770–90.
16. Tashkin DP, Elashoff R, Clements PJ, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006;354:2655–66.
17. Nannini C, West CP, Erwin PJ, et al. Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies. Arthritis Res Ther 2008;10:R124.